[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371213-105":59,"doc-detail-371213-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","circular-rna-circbnc2-inhibits-tumorigenesis-by-modulating-ferroptosis-and-acts-as-a-nanotherapeutic-target-in-prostate-cancer","Circular RNA circBNC2 inhibits tumorigenesis by modulating ferroptosis and acts as a nanotherapeutic target in prostate cancer","","Metastasis drives cancer-related death in castration-resistant prostate cancer (CRPC), yet the functional roles of circular RNAs in metastatic CRPC (mCRPC) remain insufficiently defined. This study analyzed circBNC2 expression across prostate cancer subtypes using bioinformatics, then assessed cell and animal phenotypes including proliferation, migration, invasion, and ferroptosis. Mechanistic validation involved circBNC2/miR-4298/ACSL6 interaction assays, and nanobowls delivering docetaxel plus circBNC2 were tested in photothermal therapy models.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/circular-rna-circbnc2-inhibits-tumorigenesis-by-modulating-ferroptosis-and-acts-as-a-nanotherapeutic-target-in-prostate-cancer/371213/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/circular-rna-circbnc2-inhibits-tumorigenesis-by-modulating-ferroptosis-and-acts-as-a-nanotherapeutic-target-in-prostate-cancer/371213.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does circBNC2 play in prostate cancer?","Question",{"text":112,"@type":113},"circBNC2 is identified as a tumor-suppressive circular RNA in prostate cancer, CRPC, and neuroendocrine prostate cancer samples. Its expression is significantly downregulated, and restoring its effects inhibits proliferation and migration.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does circBNC2 regulate ferroptosis?",{"text":117,"@type":113},"circBNC2 functions as a sponge for miR-4298, and ACSL6 is identified as a direct target of the circBNC2/miR-4298 axis. ACSL6 is essential for mediating circBNC2-regulated ferroptosis in prostate cancer cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic strategy involves circBNC2 and docetaxel?",{"text":121,"@type":113},"The study developed nanobowls loaded with docetaxel and circBNC2 (Dc-NBs) and evaluated their antitumor efficacy using a photothermal therapy strategy. Dc-NBs showed significant antitumor effects in both subcutaneous and metastatic prostate cancer models.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},371213,1790224756,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Pan etal. Molecular Cancer (2025) 24:29 Molecular Cancer  \n[https://doi.org/10.1186/s12943-025-02234-9](https://doi.org/10.1186/s12943-025-02234-9)  \nRESEARCH Open Access  \nCircular RNA circBNC2 inhibits tumorigenesis  by modulating ferroptosis and acts asa nanotherapeutic target in prostate cancer  \nXiang Pan 1,5†, Kailai Chen 1,5†, Wei Gao2†, Meiqi Xu 1,5, Fanlong Meng 1,5, Mengyuan Wu 1,5, Zi Qi Wang 1,3, Yun Qi Li4, Wanhai Xu 1*, Manjie Zhang2* andYakun Luo 1,5*  \nAbstract  \nBackground Metastasis is a leading cause of cancer-related death in castration-resistant prostate cancer (CRPC) patients. Circular RNAs (circRNAs) have emerged as key regulators ofthe metastasis of various cancers. However, the functional effects and regulatory mechanisms of circRNAs in metastatic CRPC (mCRPC) remain largely unknown. Methods The expression of circBNC2 in prostate cancer (PCa), CRPC and neuroendocrine prostate cancer (NEPC) tissues was analyzed through bioinformatics analysis. Functional assays, including cell proliferation, migration, invasion and ferroptosis, were conducted in vitro and in vivo. The interactions between circBNC2, miR-4298, and ACSL6 were explored via luciferase reporter assays, RNA immunoprecipitation, and western blotting analysis. In addition, for the first time in PCa, we developed novel nanobowls (NBs) loaded with docetaxel (DTX) and circBNC2 (Dc-NBs) and evaluated the antitumor efficacy of Dc-NBs in a photothermal therapy (PTT) strategy.  \nResults We identified a novel tumor-suppressive circRNA, circBNC2, in human PCa, CRPC and NEPC samples via bioinformatic analysis. CircBNC2 expression was significantly downregulated in PCa tissues and PCa cell lines.  \nFunctional assays demonstrated that circBNC2 inhibited PCa cell proliferation and migration both in vitro and in vivo. Mechanistically, circBNC2 acted as a sponge for miR-4298, and ACSL6 was identified as a direct target of the circBNC2/ miR-4298 axis. Moreover, we demonstrated that ACSL6 is essential for mediating circBNC2-regulated ferroptosis in PCa cells. More importantly, we demonstrated the nanodelivery of Dc-NBs, which exhibited significant antitumor effects in both subcutaneous and metastatic PCa models.  \n†Xiang Pan, Kailai Chen and Wei Gao contributed equally to this work.  \n*Correspondence:  \nWanhai Xu [xuwanhai@hrbmu.edu.cn](xuwanhai@hrbmu.edu.cn)[ ](xuwanhai@hrbmu.edu.cn)Manjie Zhang [zhangmj454@nenu.edu.cn](zhangmj454@nenu.edu.cn)[ ](zhangmj454@nenu.edu.cn)Yakun Luo [luoyankun@hrbmu.edu.cn](luoyankun@hrbmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nPan et al. Molecular Cancer (2025) 24:29 Page 2 of 26  \nConclusion This study revealed the tumor-suppressive role of circBNC2 in mCRPC by driving ferroptosis via the circBNC2/miR-4298/ACSL6 axis. Additionally, we developed an efficient and safe PTT strategy based on a nanodelivery system that codelivers","cbCaimSgv5MLLCGn","https://ap.wps.com/l/cbCaimSgv5MLLCGn","pdf",21281988,26,"English","# Background\n## Metastasis and CRPC context\n# Methods\n## circBNC2 expression analysis\n## Functional assays (in vitro and in vivo)\n## Interaction validation\n## Nanobowl-based photothermal therapy design\n# Results\n## circBNC2 downregulation\n## Effects on proliferation and migration\n## circBNC2/miR-4298/ACSL6 axis and ferroptosis\n## Antitumor activity in models\n# Conclusion\n## Tumor-suppressive mechanism and therapeutic potential","[{\"question\":\"What role does circBNC2 play in prostate cancer?\",\"answer\":\"circBNC2 is identified as a tumor-suppressive circular RNA in prostate cancer, CRPC, and neuroendocrine prostate cancer samples. Its expression is significantly downregulated, and restoring its effects inhibits proliferation and migration.\"},{\"question\":\"How does circBNC2 regulate ferroptosis?\",\"answer\":\"circBNC2 functions as a sponge for miR-4298, and ACSL6 is identified as a direct target of the circBNC2/miR-4298 axis. ACSL6 is essential for mediating circBNC2-regulated ferroptosis in prostate cancer cells.\"},{\"question\":\"What therapeutic strategy involves circBNC2 and docetaxel?\",\"answer\":\"The study developed nanobowls loaded with docetaxel and circBNC2 (Dc-NBs) and evaluated their antitumor efficacy using a photothermal therapy strategy. Dc-NBs showed significant antitumor effects in both subcutaneous and metastatic prostate cancer models.\"}]","Circular RNA circBNC2 inhibits tumorigenesis by modulating ferroptosis and acts as a nanotherapeutic target in prostate cancer | PDF",1790191531,66,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/245f7a24f11236c31a8e18dbe350cee7.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/190ef0aa6d8c5035df84924836647ad5.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4aa59fb2e32bd5d4219cd65157318973.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/46b98dd12d59b46798c61595efe88509.webp",980,1306]